Position | Company | Period |
---|
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-17 | 2024-04-17 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-5.6%
38.49384,890 USD |
10,000 -5.6% | 38.49 | 384,890 USD | |
2024-04-17 | 2024-04-16 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-5.6%
38.35383,500 USD |
10,000 -5.6% | 38.35 | 383,500 USD | |
2024-03-13 | 2024-03-13 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-6.0%
42.27422,730 USD |
10,000 -6.0% | 42.27 | 422,730 USD | |
2024-03-13 | 2024-03-12 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-6.0%
41.64416,370 USD |
10,000 -6.0% | 41.64 | 416,370 USD | |
2024-02-28 | 2024-02-28 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
7,471
-4.6%
39.54295,418 USD |
7,471 -4.6% | 39.54 | 295,418 USD | |
2024-02-28 | 2024-02-28 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
2,529
-1.6%
39.56100,045 USD |
2,529 -1.6% | 39.56 | 100,045 USD | |
2024-02-28 | 2024-02-27 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-5.9%
39.95399,460 USD |
10,000 -5.9% | 39.95 | 399,460 USD | |
2024-01-18 | 2024-01-17 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-6.2%
36.00360,000 USD |
10,000 -6.2% | 36.00 | 360,000 USD | |
2024-01-18 | 2024-01-16 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-6.2%
36.00360,000 USD |
10,000 -6.2% | 36.00 | 360,000 USD | |
2023-12-13 | 2023-12-13 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-6.2%
40.39403,940 USD |
10,000 -6.2% | 40.39 | 403,940 USD | |
2023-12-13 | 2023-12-12 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
643
-0.4%
40.4726,019 USD |
643 -0.4% | 40.47 | 26,019 USD | |
2023-12-13 | 2023-12-12 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
9,357
-5.8%
39.58370,303 USD |
9,357 -5.8% | 39.58 | 370,303 USD | |
2023-11-16 | 2023-11-14 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
1,708
-1.1%
39.0866,747 USD |
1,708 -1.1% | 39.08 | 66,747 USD | |
2023-11-16 | 2023-11-14 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
8,292
-5.2%
39.08324,043 USD |
8,292 -5.2% | 39.08 | 324,043 USD | |
2023-10-17 | 2023-10-17 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-6.2%
36.52365,200 USD |
10,000 -6.2% | 36.52 | 365,200 USD | |
2023-09-19 | 2023-09-19 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-6.2%
39.10390,980 USD |
10,000 -6.2% | 39.10 | 390,980 USD | |
2023-08-23 | 2023-08-22 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
8,075
-5.0%
42.41342,437 USD |
8,075 -5.0% | 42.41 | 342,437 USD | |
2023-08-23 | 2023-08-22 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
1,925
-1.3%
42.4181,633 USD |
1,925 -1.3% | 42.41 | 81,633 USD | |
2023-07-19 | 2023-07-18 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-6.6%
40.43404,300 USD |
10,000 -6.6% | 40.43 | 404,300 USD | |
2023-06-22 | 2023-06-21 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-6.6%
36.00360,000 USD |
10,000 -6.6% | 36.00 | 360,000 USD | |
2023-04-19 | 2023-04-18 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-6.6%
36.00360,000 USD |
10,000 -6.6% | 36.00 | 360,000 USD | |
2023-02-28 | 2023-02-27 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
2,984
-2.1%
49.55147,854 USD |
2,984 -2.1% | 49.55 | 147,854 USD | |
2023-02-28 | 2023-02-27 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
7,016
-4.7%
49.55347,629 USD |
7,016 -4.7% | 49.55 | 347,629 USD | |
2023-02-21 | 2023-02-16 |
Halozyme Therapeutics Inc
(HALO)
|
S Sale |
2,878
-1.9%
49.26141,770 USD |
2,878 -1.9% | 49.26 | 141,770 USD | |
2023-02-17 | 2023-02-15 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
10,000
-6.5%
48.39483,940 USD |
10,000 -6.5% | 48.39 | 483,940 USD | |
2023-01-18 | 2023-01-17 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
1,122
-0.8%
50.9357,139 USD |
1,122 -0.8% | 50.93 | 57,139 USD | |
2023-01-18 | 2023-01-17 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
8,878
-5.8%
50.40447,451 USD |
8,878 -5.8% | 50.40 | 447,451 USD | |
2022-12-13 | 2022-12-13 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
5,065
-3.2%
58.66297,133 USD |
5,065 -3.2% | 58.66 | 297,133 USD | |
2022-12-13 | 2022-12-13 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
4,935
-3.0%
58.67289,541 USD |
4,935 -3.0% | 58.67 | 289,541 USD | |
2022-11-16 | 2022-11-15 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
3,115
-1.9%
54.14168,643 USD |
3,115 -1.9% | 54.14 | 168,643 USD | |
2022-11-16 | 2022-11-15 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
8
-0.0%
54.61437 USD |
8 -0.0% | 54.61 | 437 USD | |
2022-11-16 | 2022-11-15 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
6,877
-4.0%
54.12372,183 USD |
6,877 -4.0% | 54.12 | 372,183 USD | |
2021-10-01 | 2021-10-01 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
29,450
-16.5%
39.931,175,968 USD |
29,450 -16.5% | 39.93 | 1,175,968 USD | |
2021-07-06 | 2021-07-01 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
40,315
-23.1%
45.701,842,315 USD |
40,315 -23.1% | 45.70 | 1,842,315 USD | |
2021-04-01 | 2021-04-01 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
18,994
-13.4%
42.79812,829 USD |
18,994 -13.4% | 42.79 | 812,829 USD | |
2021-04-01 | 2021-04-01 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
9,695
-6.4%
42.11408,208 USD |
9,695 -6.4% | 42.11 | 408,208 USD | |
2021-03-01 | 2021-03-01 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
6,530
-5.0%
46.26302,061 USD |
6,530 -5.0% | 46.26 | 302,061 USD | |
2021-03-01 | 2021-03-01 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
11,794
-8.4%
45.56537,303 USD |
11,794 -8.4% | 45.56 | 537,303 USD | |
2020-12-21 | 2020-12-21 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
600
-0.5%
43.2525,951 USD |
600 -0.5% | 43.25 | 25,951 USD | |
2020-12-21 | 2020-12-21 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
11,400
-8.5%
42.54484,967 USD |
11,400 -8.5% | 42.54 | 484,967 USD | |
2020-11-20 | 2020-11-20 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
7,889
-5.5%
39.04307,955 USD |
7,889 -5.5% | 39.04 | 307,955 USD | |
2020-11-20 | 2020-11-20 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
4,111
-2.8%
38.24157,221 USD |
4,111 -2.8% | 38.24 | 157,221 USD | |
2020-10-20 | 2020-10-20 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
12,000
-7.6%
30.43365,148 USD |
12,000 -7.6% | 30.43 | 365,148 USD | |
2020-09-21 | 2020-09-21 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
12,000
-7.0%
26.91322,884 USD |
12,000 -7.0% | 26.91 | 322,884 USD | |
2020-08-20 | 2020-08-20 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
12,000
-6.6%
28.30339,564 USD |
12,000 -6.6% | 28.30 | 339,564 USD | |
2020-07-20 | 2020-07-20 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
12,000
-6.2%
29.01348,072 USD |
12,000 -6.2% | 29.01 | 348,072 USD | |
2020-05-21 | 2020-05-20 |
Halozyme Therapeutics Inc
(HALO)
|
PS Planned sale |
21,387
-10.8%
23.80509,075 USD |
21,387 -10.8% | 23.80 | 509,075 USD |